-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
invivyd
-
Invivyd and Leading Researchers Form SPEAR Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID
Key points: SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. Michael Peluso, Amy Proal, and David Putrino are key thought leaders...- Jesse
- Thread
- invivyd long covid monoclonal antibody peluso pemgarda proal putrino spear
- Replies: 3
- Forum: Long Covid news